imiquimod has been researched along with qs 21 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S; Lim, YT; Noh, HJ; Noh, YW; Shin, WJ; Um, SH | 1 |
1 other study(ies) available for imiquimod and qs 21
| Article | Year |
|---|---|
Hyaluronic acid-supported combination of water insoluble immunostimulatory compounds for anti-cancer immunotherapy.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cancer Vaccines; Drug Carriers; Female; Hyaluronic Acid; Hydrogen Bonding; Imiquimod; Immunotherapy; Lipid A; Lymphoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Saponins; Solubility | 2017 |